Simplified Equations Using Two Concentrations To Calculate Area under the Curve for Antimicrobials with Concentration-Dependent Pharmacodynamics: Daptomycin as a Motivating Example

被引:39
作者
Pai, Manjunath P. [1 ]
Russo, Alessandro [2 ]
Novelli, Andrea [3 ]
Venditti, Mario [2 ]
Falcone, Marco [2 ]
机构
[1] Albany Coll Pharm & Hlth Sci, Albany, NY USA
[2] Univ Roma La Sapienza, Policlin Umberto I, Dept Publ Hlth & Infect Dis, I-00185 Rome, Italy
[3] Univ Florence, Clin Pharmacol & Oncol Sect, Florence, Italy
关键词
CRITICALLY-ILL; PHARMACOKINETICS; INFECTIONS; BACTEREMIA;
D O I
10.1128/AAC.02355-14
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The effects of several antimicrobial agents are predicted by the ratio of the area under the concentration-time curve (AUC) to the MIC (AUC/MIC). Peak (C-p) and trough (C-t) concentrations are often measured clinically as surrogates of AUC because actual computation of AUC from 1 or 2 samples requires sophisticated mathematical methods. Given that the effects of daptomycin are predicted by AUC/MIC, our objective was to compare simple equation calculated AUC based on C-p and C-t to model integrated AUC. A standard population pharmacokinetic model was used to simulate 5,000 daptomycin concentration-time profiles after 5 doses of 6 mg/kg of body weight/day (0.5-h infusions). The AUC for the 24-h period was computed by integration and by equations with 110 C-p-C-t combination pairs. The C-p time points were in 15-min increments between 0.5 h and 3 h and C-t in 15-min increments within an hour of the end of the dosing interval for each dose. The precision and bias of the calculated AUC relative to the integrated AUC were determined to identify C-p-C-t pairs associated with the lowest bias and highest precision. The equations were further validated using two daptomycin concentration-time data sets from healthy volunteers and critically ill patients. The precision and bias of calculated AUC were based primarily on C-p, and use of a daptomycin C-p 1.5 h to 3 h from the start of infusion was associated with a bias of <10% and an R2 of >0.95. Data from the healthy volunteers and critically ill patients also demonstrated declining bias with use of C-p >= 1.5 h from the start of infusion with relatively good precision. Simplified equations using a daptomycin C-p approximately 2 h from the start of infusion and a C-t within an hour of the end of the dosing interval should yield precise and unbiased estimates of daptomycin AUC.
引用
收藏
页码:3162 / 3167
页数:6
相关论文
共 22 条
[1]  
Baietto L, 2013, J PHARM BIOMED ANA C, V88C, P66
[2]   A SUGGESTED APPROACH TO ONCE-DAILY AMINOGLYCOSIDE DOSING [J].
BEGG, EJ ;
BARCLAY, ML ;
DUFFULL, SB .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 39 (06) :605-609
[3]   Daptomycin Exposure and the Probability of Elevations in the Creatine Phosphokinase Level: Data from a Randomized Trial of Patients with Bacteremia and Endocarditis [J].
Bhavnani, Sujata M. ;
Rubino, Christopher M. ;
Ambrose, Paul G. ;
Drusano, George L. .
CLINICAL INFECTIOUS DISEASES, 2010, 50 (12) :1568-1574
[4]  
D'Argenio DZ., 2009, ADAPT 5 User's Guide: Pharmacokinetic/Pharmacodynamic Systems Analysis Software
[5]   Population pharmacokinetics of daptomycin in patients affected by severe Gram-positive infections [J].
Di Paolo, Antonello ;
Tascini, Carlo ;
Polillo, Marialuisa ;
Gemignani, Giulia ;
Nielsen, Elisabet I. ;
Bocci, Guido ;
Karlsson, Mats O. ;
Menichetti, Francesco ;
Danesi, Romano .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 42 (03) :250-255
[6]   Daptomycin: From the Mountain to the Clinic, with Essential Help from Francis Tally, MD [J].
Eisenstein, Barry I. ;
Oleson, Frederick B., Jr. ;
Baltz, Richard H. .
CLINICAL INFECTIOUS DISEASES, 2010, 50 :S10-S15
[7]  
EUCAST, 2005, DAPT RAT EUCAST CLIN
[8]   Considerations for Higher Doses of Daptomycin in Critically Ill Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia [J].
Falcone, Marco ;
Russo, Alessandro ;
Venditti, Mario ;
Novelli, Andrea ;
Pai, Manjunath P. .
CLINICAL INFECTIOUS DISEASES, 2013, 57 (11) :1568-1576
[9]   Variability of pharmacokinetic parameters in patients receiving different dosages of daptomycin: is therapeutic drug monitoring necessary? [J].
Falcone, Marco ;
Russo, Alessandro ;
Cassetta, Maria Iris ;
Lappa, Angela ;
Tritapepe, Luigi ;
d'Ettorre, Gabriella ;
Fallani, Stefania ;
Novelli, Andrea ;
Venditti, Mario .
JOURNAL OF INFECTION AND CHEMOTHERAPY, 2013, 19 (04) :732-739
[10]  
JELLIFFE RW, 1990, MED PROG TECHNOL, V16, P95